Intracellular effectors and modulators of GABA-A and GABA-B receptors: a commentary

The effects of raising intracellular calcium on synaptic GABAA receptor-channels

The effects of various calcium (Ca2+) loads imposed through whole-cell patch electrodes on dentate gyrus granule cells were investigated on synaptic GABAA receptor-channels. The kinetics of spontaneous inhibitory postsynaptic currents (sIPSCs) were similar when recorded without any exogenous Ca2+ buffers in the patch electrode or with up to 30 mM BAPTA in the pipette. Unbuffered Ca2+ concentrations of 20-100 microM in the patch pipettes induced a gradual prolongation of miniature IPSC (mIPSC) decays over the course of the recording (10-40 min) with no apparent change in their rise times, peak amplitudes, or frequency of occurrence. This effect was not mimicked by other divalent cations such as strontium. Infusion into the cells of free ionic Ca2+ concentrations buffered with various affinity chelators in the pipette had more pronounced effects on synaptic GABAA currents. Free ionic Ca2+ buffered in the range of 200-400 nM with BAPTA prolonged the decay time constant of mIPSCs. Introducing buffered Ca2+ into the neurons in excess of 1 microM, with a relatively low affinity buffer such as Br2BAPTA, resulted in a marked inhibition of mIPSCs. A similar effect was observed following release of Ca2+ from intracellular stores induced by caffeine (10 mM). We conclude that Ca2+ has a biphasic effect on synaptic GABAA receptor-channels. A high affinity potentiation, consistent with a prolongation of channel burst duration, and a low affinity depression of channel activity both contribute to a complex regulation of synaptic GABAA receptors by [Ca2+]i that has a profound bearing on cellular mechanisms of plasticity and pathological alterations in neuronal excitability.

Enhancement of morphine analgesia by the GABAB agonist baclofen

Opioid-GABAergic interactions for the treatment of post-operative pain were investigated in two double-blind, placebo-controlled experiments. We first studied the effect of pre-operatively administered baclofen, a GABAB receptor agonist, on the analgesia produced by intravenously administered morphine, a predominantly mu-opioid analgesic. In a separate trial, we studied the effect of baclofen on the analgesia produced by pentazocine, a predominantly kappa-opioid analgesic. While baclofen alone did not affect the level of post-operative pain, morphine analgesia was significantly enhanced by baclofen compared to placebo. In contrast, baclofen did not affect the level of pentazocine analgesia: however, females receiving pentazocine showed significantly greater analgesia than males.

Baclofen administration for the treatment of affective disorders in alcoholic patients

Ninety alcoholic patients with the secondary affective disorders (anxiety, depression) were divided into four groups. Patients in the first group received GABAB receptor ligands (baclofen), those in the second group, diazepam, those in the third group, amitriptyline and those in the fourth group, placebo. The results of clinical, psychological (tests of Spielberger, Zung and MMPI), and electrophysiological (superslow omega-potential) investigations showed that baclofen is an effective drug for affective disturbances in alcoholic patients, with efficacy superior to placebo and equal to diazepam and amitriptyline. At the same time baclofen does not have the side-effects and complications of the latter. Significant changes in platelet MAOB activity and the dopamine, serotonin and GABA concentrations in blood after treatment were not found in the four patient groups. The peripheral matabolism of GABA and monoamines do not seem to be related to the development of secondary affective disorders in alcoholic patients. This investigation encourages the search for drugs acting on the affective psychopathology of GABAB receptor ligands.

Age-related regional sensitivity to pertussis toxin-mediated reduction in GABAB receptor binding in rat brain

GABAB binding was performed in rat brain membranes incubated with pertussis toxin (PTX; 7-15 micrograms/mg protein) or vehicle during postnatal development. In peripubertal rats, GABAB binding was reduced by PTX in corpus striatum and hippocampus but not in cortex or cerebellum, while in sexually mature adults binding was reduced in all areas except the corpus striatum. These data may indicate regional differences in the postnatal development of GABAB receptor-G protein linkage.

Regional effects of pertussis toxin in vivo and in vitro on GABAB receptor binding in rat brain

Agonist binding to GABAB receptors modulates the activity of the guanine nucleotide binding proteins, Go and Gi. These G proteins are ADP-ribosylated by pertussis toxin and this prevents them from coupling to the GABAB receptor resulting in a reduction in high-affinity GABAB binding. GTP, which binds to a different site on the G protein alpha subunit, also reduces the affinity of the receptor for the G protein, and this can be used as a "marker" for G protein-GABAB receptor linkage. We have examined GABAB binding site distribution in rat brain after unilateral intrahippocampal pertussis toxin injection in vivo, and after incubating brain slices in pertussis toxin in vitro, using the technique of receptor autoradiography. The effect of pertussis toxin was compared with that of GTP gamma S on GABAB binding. Intrahippocampal pertussis toxin administration reduced GABAB but not GABAA receptor binding and the effects appeared to be limited by pertussis toxin diffusion. More widespread reductions in GABAB binding were seen after incubation of brain slices in vitro but the extent varied in different brain regions. No reduction was detected in the corpus striatum. GABAB binding was also reduced in membranes prepared from cerebral cortex, hippocampus and cerebellum but there was no significant reduction in the corpus striatum after pertussis toxin treatment. GTP gamma S reduced GABAB binding to a similar extent in all areas studied irrespective of their sensitivity to pertussis toxin suggesting that while GABAB binding sites are linked to G proteins throughout the rat brain, those in the corpus striatum may be predominantly pertussis toxin insensitive.

The action of agonists and an antagonist of GABA on the frequency composition of the electrical activity of various brain structures of rats

The frequency composition of the electrograms (EG) of the visual area of the cortex and deep brain structures (putamen, dorsal hippocampus, medial portion of the mid-hypothalamus) were investigated in chronic experiments in 36 awake rats under the conditions of the separate and combined introduction of GABA, its agonists (muscimol, baclofen), and an antagonist (bicuculline) into the lateral ventricle of the brain. The principal effects were manifested primarily in the form of a decrease in the power of the oscillations in the 7-16 Hz region of the range (1-25 Hz) of EG frequencies analyzed. Even though these changes were unidirectional following the administration of the agonists, they nevertheless differed with respect to the degree of expressivity in the different structures. Bicuculline, injected against the background of the action of muscimol and baclofen, attenuated the effects induced by them. The possible mechanisms of the phenomena discovered are discussed.

Calcium mobilization in isolated cochlear spiral ganglion cells of the guinea pig

Single cochlear spiral ganglion cells (SGCs) were isolated using enzymatic and mechanical techniques. Intracellular free calcium ion concentrations ([Ca2+]i) in the SGCs were measured using a digital imaging microscope and the Ca(2+)-sensitive fluorescence dye fura-2. In the presence of the Ca2+ ionophore ionomycin (1 microM), there was an irreversible increase in [Ca2+]i. Depolarization by high K+ (150 mM) led to an increase in [Ca2+]i in SGCs, and this effect was reversible. The SGCs apparently possess voltage-gated calcium channels.

GABA and behavior: the role of receptor subtypes

The discovery of different GABA receptor subtypes has stimulated research relating this neurotransmitter to a variety of behavioral functions and clinical disorders. The development of new and specific GABAergic compounds has made it possible to try to identify the specific functions of these receptors. The purpose of the present review is to evaluate the data regarding the functions of the GABA receptor subtypes in different behaviors such as motor function, reproduction, learning and memory, and aggressive-defensive behaviors. A description of GABAergic functions (stress, peripheral effects, thermoregulation) that might directly or indirectly affect behavior is also included. The possible involvement of GABA in different neurological and psychiatric disorders is also discussed. Although much research has been done trying to identify the possible role of GABA in different behaviors, the role of receptor subtypes has only recently attracted attention, and only preliminary data are available at present. It is therefore evident that still much work has to be done before a clear picture of the behavioral significance of these receptor subtypes can be obtained. Nevertheless, existing data are sufficient to justify the prediction that GABAergic agents, in the near future, will be much used in the field of behavioral pharmacology. It is hoped that the present review will contribute to this. Some specific suggestions concerning the most efficient way to pursue future research are also made.

(-)-baclofen and gamma-aminobutyric acid inhibit calcium currents in isolated retinal ganglion cells

Of the various synaptic inputs known to converge upon retinal ganglion cells, the major inhibitory inputs are thought to be GABAergic. Although gamma-aminobutyric acid (GABA) is known to activate anion-selective ion channels in retinal ganglion cells, we have tested the possibility that GABA can also modulate cationic conductances in these cells, as seen in other central and peripheral neurons. Specifically, we have made whole-cell patch-clamp recordings to test whether voltage-gated calcium currents in isolated goldfish retinal ganglion cells are sensitive to GABAB receptor ligands. (-)-Baclofen and GABA inhibited calcium currents activated by moderately long depolarizations and, during large depolarizations (e.g., to 0 mV), also appeared to accelerate the rate of current decay. The calcium current inhibition induced by (-)-baclofen and GABA was not prevented by 2-hydroxysaclofen, phaclofen, or bicuculline, even though bicuculline suppressed a GABA-activated conductance in these cells. These results demonstrate the presence of baclofen- and GABA-sensitive calcium currents in vertebrate retinal ganglion cells as well as the coexistence of GABAA and GABAB receptors in individual retinal ganglion cells.

Caffeine-induced Ca2+ release inhibits GABAA responsiveness in rat identified native primary afferents

It has been shown previously that an increase in cytoplasmic Ca2+ concentration depresses the GABA-A response. However, little attention has been paid to the Ca2+ source involved. In the present study, we show that the Ca2+ increase triggered by caffeine-induced Ca2+ release from the intracellular pool inhibits the GABA-A response, whereas Ca2+ influx through voltage-activated Ca2+ channels has no effect on this response.

Perpetual inhibitory activity in mammalian brain slices generated by spontaneous GABA release

Miniature spontaneous inhibitory postsynaptic currents (sIPSCs) mediated by GABAA receptors were recorded using whole-cell patch clamp recordings in rat brain slices maintained in vitro at 34 +/- 1 degree C. We have found that firing of action potentials by principal neurons or by GABAergic interneurons is not necessary to the generation of sIPSCs since they persist in the presence of 1-5 microM tetrodotoxin (TTX). The average frequency of the discrete sIPSCs exhibits a large cell-to-cell variability and is between 5-15 Hz. The amplitudes of the sIPSCs depend on the difference between the membrane potential and the equilibrium potential for Cl- (ECl). Generally, 70-80 mV away from ECl, sIPSCs have a mean amplitude of 30-80 pA (i.e. peak conductance of 400-1000 pS) with an average decay time constant of 5.8 ms. Accordingly, unitary single sIPSCs arise from the simultaneous activation of no more than 20 GABAA receptor/channels. The perpetual barrage of spontaneous GABAergic activity is very likely to be a critical factor in the regulation of neuronal excitability and the mechanism of action of several neuroactive compounds.

Phaclofen antagonizes the antinociceptive but not the sedative effects of (-)-baclofen

1. Intraperitoneal (ip) injection of (-)-baclofen induced long-lasting antinociceptive and sedative effects in rats. 2. Phaclofen, the phosphonic derivative of baclofen, fully antagonized the antinociceptive effect of (-)-baclofen. When injected intracerebroventricularly (icv), but not ip, phaclofen antagonized in a dose-dependent fashion (50-200 micrograms) the delays in behavioral response induced by (-)-baclofen (2.5-10 mg/kg ip) in both hot plate and tail flick tests. 3. In addition phaclofen (100 micrograms icv) counteracted the loss of the righting reflex induced by (-)-baclofen (7.5-15 mg/kg ip). 4. In contrast, phaclofen (100-200 micrograms icv) counteracted only in part the sedative effect of (-)-baclofen. In rats pretreated with the antagonist (200 micrograms icv), the electrocorticographic hypersynchrony due to (-)-baclofen (5 mg/kg ip) is replaced by a synchronized pattern associated with behavioral sedation. 5. These data are consistent with the reported antagonism by phaclofen on the effects of (-)-baclofen. They also seem to indicate that in rats phaclofen-sensitive GABA-B receptors play an important role in the analgesic effects of baclofen, but only a minor role in the sedative effects of this drug.

gamma-Aminobutyric acidB receptor activation modifies agonist binding to beta-adrenergic receptors in rat brain cerebral cortex

The interaction of isoproterenol with beta-adrenergic receptor (beta AR) binding sites was measured in membranes prepared from rat brain cerebral cortical slices previously incubated in the presence or absence of gamma-aminobutyric acid (GABA) receptor agonists. Both GABA and baclofen, but not isoguvacine, altered beta AR agonist binding by increasing the affinity of both the low- and high-affinity binding sites and by increasing the proportion of low-affinity receptors. The response to baclofen was stereoselective, and the effect of GABA was not inhibited by bicuculline. The results suggest that GABAB, but not GABAA, receptor activation modifies the coupling between beta AR and stimulatory guanine nucleotide-binding protein, which may in part explain the ability of baclofen to augment isoproterenol-stimulated cyclic AMP accumulation in brain slices.

Evidence for pharmacologically distinct subsets of GABAB receptors

Activation of GABAB receptors augments neurotransmitter-stimulated cyclic AMP accumulation while inhibiting forskolin-mediated second messenger production. Previous studies have revealed that GABAB receptors are associated with a pertussis toxin sensitive G protein, such as Gi. While such a linkage is consistent with the finding that GABAB receptor activation inhibits forskolin-mediated second messenger accumulation, it fails to explain how GABAB agonists are capable of augmenting receptor-mediated cyclic AMP production. The present experiments were undertaken to explore the possible existence of pharmacologically distinct GABAB receptors in an attempt to explain this apparent discrepancy. For the study, a variety of agents were examined for their ability to inhibit GABAB binding to brain membranes and to modify isoproterenol- or forskolin-stimulated second messenger production in rat brain slices. Of the compounds studied, only 3-aminopropylphosphonic acid and 4-aminobutylphosphonic acid were found to inhibit GABAB binding. However, 4-aminobutylphosphonic acid failed to influence either isoproterenol- or forskolin-stimulated cyclic AMP production. On the other hand, while 3-aminopropylphosphonic acid also failed to affect isoproterenol-stimulated second messenger accumulation, it inhibited the forskolin-mediated response. Given this finding, and the fact that some of the agents tested are known to influence GABAB receptor function in other systems, the results indicate a multiplicity of pharmacologically distinct GABAB receptor recognition sites. This discovery paves the way for the development of more selective GABAB receptor agonists and antagonists possessing different therapeutic potentials.